WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 8 fonti

GLP-1 drugs may result in better outcomes for cancer patients, study claims

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers

Raccontata da

medpagetoday.com

independent.co.uk

prensalibre.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

independent.co.ukStai leggendo1 mesi fa

GLP-1 drugs may result in better outcomes for cancer patients, study claims

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers

Timeline cronologica

giovedì 21 maggio 2026·healio.com
GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases
CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual…
giovedì 21 maggio 2026·medpagetoday.com
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
Accumulating evidence of possible benefit warrants randomized trials, experts say

1 mesi fa

GLP-1 Weight Loss Drugs Could Stop Cancer Progressing Says New Study

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung

Leggi questa versione → originale

nbcnews.com1 mesi fa

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.

Leggi questa versione → originale

huffpost.com1 mesi fa

GLP-1 Users May Experience A Surprising Lifesaving Benefit That Has Nothing To Do With Weight Loss

A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

Leggi questa versione → originale

scmp.com1 mesi fa

How GLP-1s are more than just weight-loss wonders – but not without risk

Research suggests GLP-1s like Ozempic may help with more than just weight loss and type 2 diabetes, but experts warn of risks from abuse.

Leggi questa versione → originale

prensalibre.com1 mesi fa

Ozempic y Mounjaro podrían ralentizar la progresión de algunos cánceres, según estudios

Investigaciones exploran si el uso de fármacos GLP-1, contra obesidad y diabetes, benefician a pacientes con ciertos tipos de cáncer.

Leggi questa versione → originale

giovedì 21 maggio 2026·

nbcnews.com

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.

venerdì 22 maggio 2026·

independent.co.uk

GLP-1 drugs may result in better outcomes for cancer patients, study claims

GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers

sabato 23 maggio 2026·

huffpost.com

GLP-1 Users May Experience A Surprising Lifesaving Benefit That Has Nothing To Do With Weight Loss

A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.

sabato 23 maggio 2026·

scmp.com

How GLP-1s are more than just weight-loss wonders – but not without risk

Research suggests GLP-1s like Ozempic may help with more than just weight loss and type 2 diabetes, but experts warn of risks from abuse.

domenica 24 maggio 2026·

prensalibre.com

Ozempic y Mounjaro podrían ralentizar la progresión de algunos cánceres, según estudios

Investigaciones exploran si el uso de fármacos GLP-1, contra obesidad y diabetes, benefician a pacientes con ciertos tipos de cáncer.

lunedì 25 maggio 2026·

forbes.com

GLP-1 Weight Loss Drugs Could Stop Cancer Progressing Says New Study

GLP-1 drugs commonly used for weight loss and diabetes decreased the risk of cancer spreading in patients with several different types of tumors including breast and lung